Application of DTI and fMRI in moyamoya disease

Xiaokuan Hao1, Ziqi Liu1, Shihao He1,2

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Frontiers in Neurology
|August 22, 2022
PubMed

Insights

Moyamoya disease (MMD) involves progressive cerebrovascular stenosis. This review examines how diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI) assess brain structure and function changes in MMD patients.

Area of Science:

  • Neuroimaging
  • Cerebrovascular Diseases
  • Neurology

Background:

  • Moyamoya disease (MMD) is a chronic, progressive cerebrovascular disorder characterized by stenosis or occlusion of major intracranial arteries near the Circle of Willis.
  • Cognitive impairment is a significant consequence of the microstructural and functional brain changes associated with MMD.

Purpose of the Study:

  • To review the principles and applications of Diffusion Tensor Imaging (DTI) in evaluating white matter integrity in MMD.
  • To review the principles and applications of functional Magnetic Resonance Imaging (fMRI) in assessing gray matter function in MMD.
  • To discuss the current challenges and future directions for DTI and fMRI in the study and management of Moyamoya disease.

Main Methods:

  • Review of scientific literature focusing on the application of DTI for white matter microstructure analysis.
  • Review of scientific literature focusing on the application of fMRI for gray matter function assessment.
  • Synthesis of findings regarding the utility and limitations of these neuroimaging techniques in Moyamoya disease.

Main Results:

  • DTI provides insights into white matter damage, a key factor in cognitive decline in MMD.
  • fMRI reveals alterations in brain activity and functional connectivity related to gray matter changes in MMD.
  • Both techniques offer valuable, yet challenging, approaches to understanding MMD's impact on the brain.

Conclusions:

  • DTI and fMRI are crucial neuroimaging tools for characterizing the structural and functional brain abnormalities in Moyamoya disease.
  • Understanding the capabilities and limitations of DTI and fMRI is essential for advancing research and clinical care for MMD patients.
  • Further research is needed to overcome current challenges and optimize the use of these advanced imaging techniques in MMD.